Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Objective: The aim of the current study is to evaluate the effects of combined omega-3 and vitamin E supplementation on metabolic profiles in gestational diabetes. Study design: parallel double-blind randomized controlled clinical trial. Inclusion and Exclusion criteria: pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation will be included in this study. The use of substitute treatments including hormone or vitamin supplements as well as those with pre-eclampsia, complete bed rest (CBR), intra uterine fetal death (IUFD), placenta abruption and preterm delivery will be excluded in the study. Population and sample size: 60 patients with GDM among pregnant women of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected. Intervention: Patients will be assigned to receive either omega-3 plus vitamin E supplements (intervention group: n=30) or placebo (control group: n=30). Fasting blood samples will be taken at baseline and after 6-wk intervention to measure metabolic profiles. Start and End Date of Intervention: 6 weeks. Outcomes: Fasting plasma glucose (FPG), serum insulin levels and lipid profiles will be measured at study baseline and end-of-trial
empty
Objective: The aim of the current study is to evaluate the effects of combined omega-3 and vitamin E supplementation on metabolic profiles in gestational diabetes. Study design: parallel double-blind randomized controlled clinical trial. Inclusion and Exclusion criteria: pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation will be included in this study. The use of substitute treatments including hormone or vitamin supplements as well as those with pre-eclampsia, complete bed rest (CBR), intra uterine fetal death (IUFD), placenta abruption and preterm delivery will be excluded in the study. Population and sample size: 60 patients with GDM among pregnant women of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected. Intervention: Patients will be assigned to receive either omega-3 plus vitamin E supplements (intervention group: n=30) or placebo (control group: n=30). Fasting blood samples will be taken at baseline and after 6-wk intervention to measure metabolic profiles. Start and End Date of Intervention: 6 weeks. Outcomes: Fasting plasma glucose (FPG), serum insulin levels and lipid profiles will be measured at study baseline and end-of-trial
هدف: هدف مطالعه حاضر ارزیابی اثرات مکمل یاری ترکیب امگا-3 و ویتامین E بر پروفایل های متابولیک در دیابت بارداری است. طراحی مطالعه: تصادفي کارآزمایی بالینی دو سوکور موازی. معیار ورود و خروج مطالعه: زنان باردار 40-18 ساله مبتلا به دیابت بارداری (GDM) در هفته 28-24 بارداری، در این مطالعه وارد خواهند شد. استفاده از درمان های جایگزین از قبیل هورمون یا مکمل ویتامینی و همچنین آن هایی که مبتلا به پری اکلامسی، استراحت مطلق، مرگ جنینی داخل رحمی، جدا شدن جفت و زایمان زودرس می شوند از مطالعه خارج خواهند شد. حجم نمونه و جمعیت مورد مطالعه: 60 زن باردار مبتلا به دیابت بارداری واجد شرایط و ارجاع شده به کلینیک نقوی وابسته به دانشگاه علوم پزشکی کاشان، کاشان، ایران در مطالعه انتخاب خواهند شد. مداخله مورد مطالعه: بیماران برای دریافت مکمل امگا-3 بعلاوه ویتامین E (گروه مداخله: 30n=) یا پلاسبو (گروه کنترل30n=) تقسیم خواهند شد. نمونه خون ناشتا در ابتدای مطالعه و 6 هفته بعد از مداخله برای تعیین پروفایل های متابولیک از بیماران گرفته خواهد شد. زمان شروع و اتمام مداخله: 6 هفته. پيامدها: گلوکز پلاسمایی ناشتا، سطوح انسولین سرمی و پروفایل های لیپیدی در ابتدا و انتهای مداخله اندازه گیری خواهد شد.
empty
هدف: هدف مطالعه حاضر ارزیابی اثرات مکمل یاری ترکیب امگا-3 و ویتامین E بر پروفایل های متابولیک در دیابت بارداری است. طراحی مطالعه: تصادفي کارآزمایی بالینی دو سوکور موازی. معیار ورود و خروج مطالعه: زنان باردار 40-18 ساله مبتلا به دیابت بارداری (GDM) در هفته 28-24 بارداری، در این مطالعه وارد خواهند شد. استفاده از درمان های جایگزین از قبیل هورمون یا مکمل ویتامینی و همچنین آن هایی که مبتلا به پری اکلامسی، استراحت مطلق، مرگ جنینی داخل رحمی، جدا شدن جفت و زایمان زودرس می شوند از مطالعه خارج خواهند شد. حجم نمونه و جمعیت مورد مطالعه: 60 زن باردار مبتلا به دیابت بارداری واجد شرایط و ارجاع شده به کلینیک نقوی وابسته به دانشگاه علوم پزشکی کاشان، کاشان، ایران در مطالعه انتخاب خواهند شد. مداخله مورد مطالعه: بیماران برای دریافت مکمل امگا-3 بعلاوه ویتامین E (گروه مداخله: 30n=) یا پلاسبو (گروه کنترل30n=) تقسیم خواهند شد. نمونه خون ناشتا در ابتدای مطالعه و 6 هفته بعد از مداخله برای تعیین پروفایل های متابولیک از بیماران گرفته خواهد شد. زمان شروع و اتمام مداخله: 6 هفته. پيامدها: گلوکز پلاسمایی ناشتا، سطوح انسولین سرمی و پروفایل های لیپیدی در ابتدا و انتهای مداخله اندازه گیری خواهد شد.
empty
Objective: The aim of the current study is to evaluate the effects of combined omega-3 and vitamin E supplementation on metabolic profiles in gestational diabetes.
Objective: The aim of the current study is to evaluate the effects of combined omega-3 and vitamin E supplementation on metabolic profiles in gestational diabetes.
empty
هدف: هدف مطالعه حاضر ارزیابی اثرات مکمل یاری ترکیب امگا-3 و ویتامین E بر پروفایل های متابولیک در دیابت بارداری است.
هدف: هدف مطالعه حاضر ارزیابی اثرات مکمل یاری ترکیب امگا-3 و ویتامین E بر پروفایل های متابولیک در دیابت بارداری است.
empty
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial. Random assignment will be done by the use of computer-generated random numbers.
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial. Random assignment will be done by the use of computer-generated random numbers.
empty
طراحي انجام مطالعه: تصادفي کارآزمایی بالینی دو سوکور (هم بیماران و هم محققان) موازی. تصادفی سازی با استفاده از اعداد تصادفی ایجاد شده توسط کامپیوتر انجام خواهد شد.
طراحي انجام مطالعه: تصادفي کارآزمایی بالینی دو سوکور (هم بیماران و هم محققان) موازی. تصادفی سازی با استفاده از اعداد تصادفی ایجاد شده توسط کامپیوتر انجام خواهد شد.
empty
Population and sample size: 60 patients with gestational diabetes of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected.
Population and sample size: 60 patients with gestational diabetes of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected.
empty
حجم نمونه و جمعیت مورد مطالعه: 60 بیمار مبتلا به دیابت بارداری واجد شرایط و ارجاع شده به کلینیک نقوی وابسته به دانشگاه علوم پزشکی کاشان، کاشان، ایران در مطالعه انتخاب خواهند شد.
حجم نمونه و جمعیت مورد مطالعه: 60 بیمار مبتلا به دیابت بارداری واجد شرایط و ارجاع شده به کلینیک نقوی وابسته به دانشگاه علوم پزشکی کاشان، کاشان، ایران در مطالعه انتخاب خواهند شد.
empty
Inclusion criteria: Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation. Exclusion criteria: Patients with premature preterm rupture of membrane, placenta abruption, pre-eclampsia, eclampsia, hypo and hyperthyroidism, urinary tract infection, smokers, kidney or liver diseases, required commencing insulin therapy during intervention
Inclusion criteria: Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation. Exclusion criteria: Patients with premature preterm rupture of membrane, placenta abruption, pre-eclampsia, eclampsia, hypo and hyperthyroidism, urinary tract infection, smokers, kidney or liver diseases, required commencing insulin therapy during intervention
empty
معیارهای ورود مطالعه: زنان باردار 40-18 ساله مبتلا به دیابت بارداری (GDM) در هفته 28-24 بارداری.
معیارهای خروج مطالعه: بیماران مبتلا به پارگی زودرس غشاء، جدا شدن زودرس جفت، پره اکلامسی، اکلامپسی، کم و پرکاری تیروئید، عفونت مجرای ادراری، بیماری های کلیوی و کبدی، نیاز به شروع انسولین درمانی در طی مداخله.
معیارهای ورود مطالعه: زنان باردار 40-18 ساله مبتلا به دیابت بارداری (GDM) در هفته 28-24 بارداری. معیارهای خروج مطالعه: بیماران مبتلا به پارگی زودرس غشاء، جدا شدن زودرس جفت، پره اکلامسی، اکلامپسی، کم و پرکاری تیروئید، عفونت مجرای ادراری، بیماری های کلیوی و کبدی، نیاز به شروع انسولین درمانی در طی مداخله.
empty
Intervention group: Combined omega-3 and vitamin E pearl, 1000 mg omega-3 and 400 IU vitamin E, daily, for 6 weeks orally.
Control group: Placebo pearl, daily, for 6 weeks orally.
Intervention group: Combined omega-3 and vitamin E pearl, 1000 mg omega-3 and 400 IU vitamin E, daily, for 6 weeks orally. Control group: Placebo pearl, daily, for 6 weeks orally.
empty
گروه مداخله: ترکیب پرل امگا-3 و ویتامین E، 1000 میلی گرم امگا-3 و 400 واحد ویتامین E، روزانه، به صورت خوراکی برای 6 هفته.
گروه کنترل: پرل پلاسبو، روزانه، به صورت خوراکی برای 6 هفته.
گروه مداخله: ترکیب پرل امگا-3 و ویتامین E، 1000 میلی گرم امگا-3 و 400 واحد ویتامین E، روزانه، به صورت خوراکی برای 6 هفته. گروه کنترل: پرل پلاسبو، روزانه، به صورت خوراکی برای 6 هفته.
empty
Outcomes: Glucose homoeostasis parameters (primary outcomes) and lipid profiles (secondary outcome) will be quantified at study baseline and end-of-trial.
Outcomes: Glucose homoeostasis parameters (primary outcomes) and lipid profiles (secondary outcome) will be quantified at study baseline and end-of-trial.
empty
پيامدها: پارامترهای هموستاز گلوکز (پیامدهای اولیه) و پروفایل های لیپیدی (پیامدهای ثانویه) در ابتدا و انتهای مداخله اندازه گیری خواهد شد.
پيامدها: پارامترهای هموستاز گلوکز (پیامدهای اولیه) و پروفایل های لیپیدی (پیامدهای ثانویه) در ابتدا و انتهای مداخله اندازه گیری خواهد شد.
General information
1
1
1
1
1
1
2
3
23
empty
Due to an error, the request for an update in our website was conducted after paper published. However, the revisions were accordance with either the original approved proposal or with coordination with Vice Chancellor of Research at the University.
Due to an error, the request for an update in our website was conducted after paper published. However, the revisions were accordance with either the original approved proposal or with coordination with Vice Chancellor of Research at the University.
empty
بخاطر یک اشتباه، درخواست برای بروزرسانی در وب سایت ما بعد از چاپ مقاله انجام شد. اگرچه، اصلاحات مطابق با یا پروپوزال تصویب شده اولیه یا با هماهنگی معاونت پژوهشی دانشگاه بود.
بخاطر یک اشتباه، درخواست برای بروزرسانی در وب سایت ما بعد از چاپ مقاله انجام شد. اگرچه، اصلاحات مطابق با یا پروپوزال تصویب شده اولیه یا با هماهنگی معاونت پژوهشی دانشگاه بود.
Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation
Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation
زنان باردار 40-18 ساله مبتلا به دیابت بارداری (GDM) در هفته 28-24 بارداری
زنان باردار 40-18 ساله مبتلا به دیابت بارداری (GDM) در هفته 28-24 بارداری
Patients with premature preterm rupture of membrane
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Urinary tract infection
Smokers
Kidney or liver diseases
Required commencing insulin therapy during intervention
Patients with premature preterm rupture of membrane Placenta abruption Pre-eclampsia Eclampsia Hypo and hyperthyroidism Urinary tract infection Smokers Kidney or liver diseases Required commencing insulin therapy during intervention
بیماران مبتلا به پارگی زودرس غشاء
جدا شدن زودرس جفت
پره اکلامسی
اکلامپسی
کم و پرکاری تیروئید
عفونت مجرای ادراری
بیماری های کلیوی و کبدی
نیاز به شروع انسولین درمانی در طی مداخله
بیماران مبتلا به پارگی زودرس غشاء جدا شدن زودرس جفت پره اکلامسی اکلامپسی کم و پرکاری تیروئید عفونت مجرای ادراری بیماری های کلیوی و کبدی نیاز به شروع انسولین درمانی در طی مداخله
empty
At study baseline, after balanced blocked randomisation, subjects will be allocated into two groups to take supplements (n=30) or the standard diet (n=30). Randomization will be done by the use of computer-generated random numbers.
At study baseline, after balanced blocked randomisation, subjects will be allocated into two groups to take supplements (n=30) or the standard diet (n=30). Randomization will be done by the use of computer-generated random numbers.
empty
در ابتدای مطالعه، بعد از تصادفی سازی بلوکی بالانس شده، افراد به دو گروه برای دریافت مکمل (n=30) و پلاسبو (n=30) تخصیص داده می شوند. تصادفی سازی با استفاده از اعداد تصادفی ایجاد شده توسط کامپیوتر انجام خواهد شد.
در ابتدای مطالعه، بعد از تصادفی سازی بلوکی بالانس شده، افراد به دو گروه برای دریافت مکمل (n=30) و پلاسبو (n=30) تخصیص داده می شوند. تصادفی سازی با استفاده از اعداد تصادفی ایجاد شده توسط کامپیوتر انجام خواهد شد.
empty
Participants, investigators or the assessors of the outcomes are unaware of the study groups.
Participants, investigators or the assessors of the outcomes are unaware of the study groups.
empty
شرکت کنندگان و هم محققان یا ارزیابان پیامد از تخصیص گروههای مطالعه بی اطلاعند.
شرکت کنندگان و هم محققان یا ارزیابان پیامد از تخصیص گروههای مطالعه بی اطلاعند.
empty
empty
Primary outcomes
#1
Baseline and End-of-trial
At the beginning of the study and after 6 weeks of intervention
BaselineAt the beginning of the study and End-after 6 weeks of-trial intervention
ابتدا و انتهای مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
ابتدادر ابتدای مطالعه و انتهای6 هفته بعد از مداخله
#2
Baseline and End-of-trial
At the beginning of the study and after 6 weeks of intervention
BaselineAt the beginning of the study and End-after 6 weeks of-trial intervention
ابتدا و انتهای مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
ابتدادر ابتدای مطالعه و انتهای6 هفته بعد از مداخله
#3
Triglycerides
Insulin resistance
TriglyceridesInsulin resistance
تری گلیسرید
مقاومت به انسولین
تری گلیسریدمقاومت به انسولین
Baseline and End-of-trial
At the beginning of the study and after 6 weeks of intervention
BaselineAt the beginning of the study and End-after 6 weeks of-trial intervention
ابتدا و انتهای مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
ابتدادر ابتدای مطالعه و انتهای6 هفته بعد از مداخله
Enzymatic
Calculation using HOMA formula
EnzymaticCalculation using HOMA formula
آنزیمی
محاسبه با فرمول HOMA
آنزیمیمحاسبه با فرمول HOMA
#4
Total cholesterol
empty
Total cholesterol
کلسترول تام
empty
کلسترول تام
Baseline and End-of-trial
empty
Baseline and End-of-trial
ابتدا و انتهای مداخله
empty
ابتدا و انتهای مداخله
Enzymatic
empty
Enzymatic
آنزیمی
empty
آنزیمی
#5
HDL-cholesterol
empty
HDL-cholesterol
کلسترول HDL
empty
کلسترول HDL
Baseline and End-of-trial
empty
Baseline and End-of-trial
ابتدا و انتهای مداخله
empty
ابتدا و انتهای مداخله
Enzymatic
empty
Enzymatic
آنزیمی
empty
آنزیمی
Secondary outcomes
#1
empty
Triglycerides
Triglycerides
empty
تری گلیسرید
تری گلیسرید
empty
At the beginning of the study and after 6 weeks of intervention
At the beginning of the study and after 6 weeks of intervention
empty
در ابتدای مطالعه و 6 هفته بعد از مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#2
empty
HDL-cholesterol
HDL-cholesterol
empty
کلسترول HDL
کلسترول HDL
empty
At the beginning of the study and after 6 weeks of intervention
At the beginning of the study and after 6 weeks of intervention
empty
در ابتدای مطالعه و 6 هفته بعد از مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#3
empty
Total cholesterol
Total cholesterol
empty
کلسترول تام
کلسترول تام
empty
At the beginning of the study and after 6 weeks of intervention
At the beginning of the study and after 6 weeks of intervention
empty
در ابتدای مطالعه و 6 هفته بعد از مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#4
empty
VLDL
VLDL
empty
VLDL
VLDL
empty
At the beginning of the study and after 6 weeks of intervention
At the beginning of the study and after 6 weeks of intervention
empty
در ابتدای مطالعه و 6 هفته بعد از مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#5
empty
LDL
LDL
empty
LDL
LDL
empty
At the beginning of the study and after 6 weeks of intervention
At the beginning of the study and after 6 weeks of intervention
empty
در ابتدای مطالعه و 6 هفته بعد از مداخله
در ابتدای مطالعه و 6 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
Recruitment centers
#1
Name of recruitment center - English: Naghavi Clinic
Name of recruitment center - Persian: کلینیک نقوی
Full name of responsible person - English:
Full name of responsible person - Persian:
Street address - English:
Street address - Persian:
City - English: Kashan
City - Persian: کاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
Name of recruitment center - English: Naghavi Clinic
Name of recruitment center - Persian: کلینیک نقوی
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Street address - English: Shahid Rajaee Avenue, Kashan
Street address - Persian: کاشان، خیابان شهید رجایی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 81151-87159
Phone: +98 31 5546 3378
Fax:
Email: asemi_r@yahoo.com
Web page address:
Name of recruitment center - English: Naghavi Clinic Name of recruitment center - Persian: کلینیک نقوی Full name of responsible person - English: Zatollah Asemi Full name of responsible person - Persian: ذات اله عاصمی Street address - English: Shahid Rajaee Avenue, Kashan Street address - Persian: کاشان، خیابان شهید رجایی City - English: Kashan City - Persian: کاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 81151-87159 Phone: +98 31 5546 3378 Fax: Email: asemi_r@yahoo.com Web page address:
Sponsors / Funding sources
#1
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Science
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Street address - English: Bolvare Ghotbe Ravandi, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Science
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Gholamali Hamidi
Full name of responsible person - Persian: غلامعلی حمیدی
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 81151-87159
Phone: +98 31 5554 2999
Fax:
Email: research@kaums.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Science Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Zatollah AsemiGholamali Hamidi Full name of responsible person - Persian: ذات اله عاصمیغلامعلی حمیدی Street address - English: Bolvare Ghotbe Ravandi Boulevard, Kashan Street address - Persian: کاشان، بلوار قطب راوندی City - English: Kashan City - Persian: کاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 81151-87159 Phone: +98 31 5554 2999 Fax: Email: research@kaums.ac.ir Web page address:
empty
Public
public
empty
Domestic
domestic
empty
Academic
academic
Person responsible for general inquiries
contact.organization_id:
Name of organization / entity - English:
Name of organization / entity - Persian:
Full name of responsible person - English:
Full name of responsible person - Persian:
Position - English:
Position - Persian:
Latest degree:
Area of specialty/work:
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English:
Street address - Persian:
City - English:
City - Persian:
Province:
Province - English:
Province - Persian:
contact.provinces_available:
Country:
Postal code:
Phone:
Mobile:
Fax:
Email:
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Sciences
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Position - English: Associate professor
Position - Persian: دانشیار
Latest degree: phd
Area of specialty/work: 34
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 81151-87159
Phone: +98 31 5546 3378
Mobile: 00
Fax:
Email: asemi_z@kaums.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Sciences Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Zatollah Asemi Full name of responsible person - Persian: ذات اله عاصمی Position - English: Associate professor Position - Persian: دانشیار Latest degree: phd Area of specialty/work: 34 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Ghotbe Ravandi Boulevard, Kashan Street address - Persian: کاشان، بلوار قطب راوندی City - English: Kashan City - Persian: کاشان Province: Isfehan Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 81151-87159 Phone: +98 31 5546 3378 Mobile: 00 Fax: Email: asemi_z@kaums.ac.ir Web page address:
Person responsible for scientific inquiries
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Science
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Position - English: PhD of Nutrition
Position - Persian: دکتری تغذیه
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bolvare Ghotbe Ravandi, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 31 5546 3378
Mobile: +98 913 361 5446
Fax:
Email: asemi_z@kaums.ac.ir-asemi_r@yahoo.com
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Science
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Position - English: PhD of Nutrition
Position - Persian: دکتری تغذیه
Latest degree: phd
Area of specialty/work: 34
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Bolvare Ghotbe Ravandi, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 81151-87159
Phone: +98 31 5546 3378
Mobile: +98 913 361 5446
Fax:
Email: asemi_r@yahoo.com
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Science Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Zatollah Asemi Full name of responsible person - Persian: ذات اله عاصمی Position - English: PhD of Nutrition Position - Persian: دکتری تغذیه Latest degree: phd Area of specialty/work: 034 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Bolvare Ghotbe Ravandi, Kashan Street address - Persian: کاشان، بلوار قطب راوندی City - English: Kashan City - Persian: کاشان Province: Isfehan Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 81151-87159 Phone: +98 31 5546 3378 Mobile: +98 913 361 5446 Fax: Email: asemi_z@kaums.ac.ir-asemi_r@yahoo.com Web page address:
Person responsible for updating data
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Science
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Position - English: PhD of Nutrition
Position - Persian: دکتری تغذیه
Latest degree:
Area of specialty/work: 0
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English:
Street address - Persian:
City - English:
City - Persian:
Province:
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code:
Phone: +98 31 5546 3378
Mobile: +98 913 361 5446
Fax:
Email: asemi_z@kaums.ac.ir; asemi_r@yahoo.com
Web page address:
contact.organization_id:
Name of organization / entity - English: Kashan University of Medical Science
Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Zatollah Asemi
Full name of responsible person - Persian: ذات اله عاصمی
Position - English: PhD of Nutrition
Position - Persian: دکتری تغذیه
Latest degree: phd
Area of specialty/work: 34
Area of specialty/work title - English:
Area of specialty/work title - Persian:
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Province - English:
Province - Persian:
contact.provinces_available: 1
Country: Iran (Islamic Republic of)
Postal code: 81151-87159
Phone: +98 31 5546 3378
Mobile: +98 913 361 5446
Fax:
Email: asemi_r@yahoo.com
Web page address:
contact.organization_id: Name of organization / entity - English: Kashan University of Medical Science Name of organization / entity - Persian: دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Zatollah Asemi Full name of responsible person - Persian: ذات اله عاصمی Position - English: PhD of Nutrition Position - Persian: دکتری تغذیه Latest degree: phd Area of specialty/work: 034 Area of specialty/work title - English: Area of specialty/work title - Persian: Street address - English: Ghotbe Ravandi Boulevard, Kashan Street address - Persian: کاشان، بلوار قطب راوندی City - English: Kashan City - Persian: کاشان Province: Isfehan Province - English: Province - Persian: contact.provinces_available: 1 Country: Iran (Islamic Republic of) Postal code: 81151-87159 Phone: +98 31 5546 3378 Mobile: +98 913 361 5446 Fax: Email: asemi_z@kaums.ac.ir; asemi_r@yahoo.com Web page address:
Sharing plan
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
undecided
empty
Undecided - It is not yet known if there will be a plan to make this available.
Undecided - It is not yet known if there will be a plan to make this available.
empty
هنوز تصمیم نگرفتهام - برنامه انتشار آن هنوز مشخص نیست.
هنوز تصمیم نگرفتهام - برنامه انتشار آن هنوز مشخص نیست.
Protocol summary
Study aim
Objective: The aim of the current study is to evaluate the effects of combined omega-3 and vitamin E supplementation on metabolic profiles in gestational diabetes.
Design
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial. Random assignment will be done by the use of computer-generated random numbers.
Settings and conduct
Population and sample size: 60 patients with gestational diabetes of eligible and referred to Naghavi Clinic affiliated to Kashan University of Medical Sciences, Kashan, Iran in the study will be selected.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation. Exclusion criteria: Patients with premature preterm rupture of membrane, placenta abruption, pre-eclampsia, eclampsia, hypo and hyperthyroidism, urinary tract infection, smokers, kidney or liver diseases, required commencing insulin therapy during intervention
Intervention groups
Intervention group: Combined omega-3 and vitamin E pearl, 1000 mg omega-3 and 400 IU vitamin E, daily, for 6 weeks orally.
Control group: Placebo pearl, daily, for 6 weeks orally.
Main outcome variables
Outcomes: Glucose homoeostasis parameters (primary outcomes) and lipid profiles (secondary outcome) will be quantified at study baseline and end-of-trial.
General information
Reason for update
Due to an error, the request for an update in our website was conducted after paper published. However, the revisions were accordance with either the original approved proposal or with coordination with Vice Chancellor of Research at the University.
Acronym
IRCT registration information
IRCT registration number:IRCT201506085623N43
Registration date:2015-06-23, 1394/04/02
Registration timing:retrospective
Last update:2019-10-19, 1398/07/27
Update count:1
Registration date
2015-06-23, 1394/04/02
Registrant information
Name
Zatollah Asemi
Name of organization / entity
Kashan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 36 1534 3570
Email address
asemi_z@kaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Kashan University of Medical Science
Expected recruitment start date
2015-05-31, 1394/03/10
Expected recruitment end date
2015-06-14, 1394/03/24
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of combined omega-3 and vitamin E supplementation on metabolic profiles in gestational diabetes
Public title
Effect of supplementation in treatment of gestational diabetes
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation
Exclusion criteria:
Patients with premature preterm rupture of membrane
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Urinary tract infection
Smokers
Kidney or liver diseases
Required commencing insulin therapy during intervention
Age
From 18 years old to 40 years old
Gender
Female
Phase
3
Groups that have been masked
Participant
Investigator
Outcome assessor
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
At study baseline, after balanced blocked randomisation, subjects will be allocated into two groups to take supplements (n=30) or the standard diet (n=30). Randomization will be done by the use of computer-generated random numbers.
Blinding (investigator's opinion)
Double blinded
Blinding description
Participants, investigators or the assessors of the outcomes are unaware of the study groups.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Kashan University of Medical Science
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
81151-87159
Approval date
2015-05-31, 1394/03/10
Ethics committee reference number
9434
Health conditions studied
1
Description of health condition studied
Gestational diabetes mellitus
ICD-10 code
O24.9
ICD-10 code description
Diabetes mellitus in pregnancy, unspecified
Primary outcomes
1
Description
Fasting plasma glucose
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Enzymatic
2
Description
Insulin
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Elisa
3
Description
Insulin resistance
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Calculation using HOMA formula
Secondary outcomes
1
Description
Triglycerides
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Enzymatic kit
2
Description
HDL-cholesterol
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Enzymatic kit
3
Description
Total cholesterol
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Enzymatic kit
4
Description
VLDL
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Enzymatic kit
5
Description
LDL
Timepoint
At the beginning of the study and after 6 weeks of intervention
Method of measurement
Enzymatic kit
Intervention groups
1
Description
Intervention group: Combined omega-3 and vitamin E pearl, 1000 mg omega-3 and 400 IU vitamin E, daily, for 6 weeks orally.
Category
Treatment - Drugs
2
Description
Control group: Placebo pearl, daily, for 6 weeks orally.
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Naghavi Clinic
Full name of responsible person
Zatollah Asemi
Street address
Shahid Rajaee Avenue, Kashan
City
Kashan
Province
Isfehan
Postal code
81151-87159
Phone
+98 31 5546 3378
Email
asemi_r@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Kashan University of Medical Science
Full name of responsible person
Gholamali Hamidi
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
81151-87159
Phone
+98 31 5554 2999
Email
research@kaums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kashan University of Medical Science
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Zatollah Asemi
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
81151-87159
Phone
+98 31 5546 3378
Email
asemi_z@kaums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Kashan University of Medical Science
Full name of responsible person
Zatollah Asemi
Position
PhD of Nutrition
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Bolvare Ghotbe Ravandi, Kashan
City
Kashan
Province
Isfehan
Postal code
81151-87159
Phone
+98 31 5546 3378
Fax
Email
asemi_r@yahoo.com
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Kashan University of Medical Science
Full name of responsible person
Zatollah Asemi
Position
PhD of Nutrition
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
81151-87159
Phone
+98 31 5546 3378
Fax
Email
asemi_r@yahoo.com
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available